Table 2.

Baseline characteristics of the 23 people who dropped out after randomization by group

Characteristic	Placebo (10) (mean ± SD)	Metformin (13) (mean ± SD)	P-value*
Age (years)	54.67±5.43	56.78±7.0	0.52
Sex (n, %)	Male (2, 20%)	Male (1, 8%)
	Female (8, 80%)	Female (12, 92%)
Weight (kg)	85.63±17.35	85.86±16.95	0.91
Waist circumference (cm)	96.68±13.01	99.18±12.36	0.10
Diastolic pressure (mmHg)	90.83±10.63	86.33±14.43	0.50
Systolic pressure (mmHg)	144.67±19.53	135.56±31.44	0.50
Glycemia (mg/dL)	97.5±7.56	98.44±7.0	0.81
Total cholesterol (mg/dL)	196.5±28.87	217±25.56	0.19
HDL (mg/dL)	56.0±15.62	57.4±15.94	0.46
LDL (mg/dL)	121.83±30.45	136.89±27.02	0.35
Triglycerides (mg/dL)	99.50±42.64	102.55±45.46	0.90
AST (IU/L)	23.67±6.81	20.78±6.83	0.44
ALT (IU/L)	28.5±14.31	27.67±18.92	0.92
GammaGT (IU/L)	30.83±15.52	31.88±17.78	0.91
Education (n, %)
Junior high school	(2, 20%)	(3, 23%)	0.17
High school	(6, 60%)	(9, 69%)
University	(2, 20%)	(1, 8%)
Working/retired (n, %)
Worker	(7, 70%)	(10, 69%)	0.99
Retired	(3, 30%)	(3, 31%)

Note:

^*Student’s t-test P-value for continuous variables, chi-squared test P-value for qualitative variables.

Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein.